EUVIMEDEUVIMED entdecken
Crossref

Comments on the "Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis"

Erkan Mavigök

Journal of Controversies in Obstetrics & Gynecology and Pediatrics · 30.07.2026 · 4 (3) · 79-82

DOI: 10.51271/jcogp-0078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controversies in Obstetrics & Gynecology and Pediatrics, online erschienen am 30.07.2026. Verfasst von Erkan Mavigök.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is increasingly recognized as a systemic inflammatory condition, and dienogest is widely used as a medical treatment option. In their recent article, Bulut Arıkan and Sağsöz reported that dienogest therapy in women with endometriosis was associated with reductions in CA125, platelet-to-lymphocyte ratio (PLR), leukocyte count, and plateletcrit, alongside small increases in hemoglobin, hematocrit, and red blood cell indices. Based on these findings, the authors suggested that dienogest may exert anti-inflammatory effects and preserve endocrine homeostasis. In this letter, we highlight several methodological and interpretative issues that warrant caution. The retrospective, single-center, uncontrolled pre–post design and generally small effect sizes limit the extent to which causality and clinical significance can be inferred. Moreover, key systemic inflammatory indices such as neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index did not change significantly, which argues against a broad systemic anti-inflammatory effect. Finally, the proposed mechanisms for hematological improvement and endocrine safety remain speculative in the absence of detailed clinical outcomes.

Zitieren

APA

Mavigök, E. (2026). Comments on the "Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis". Journal of Controversies in Obstetrics & Gynecology and Pediatrics, 4(3), 79-82. https://doi.org/10.51271/jcogp-0078

Vancouver

Mavigök E. Comments on the "Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis". Journal of Controversies in Obstetrics & Gynecology and Pediatrics. 2026;4(3):79-82. doi:10.51271/jcogp-0078

BibTeX
@article{Mavigk2026,
  author = {Mavigök, Erkan},
  title = {Comments on the "Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis"},
  journal = {Journal of Controversies in Obstetrics & Gynecology and Pediatrics},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {79--82},
  doi = {10.51271/jcogp-0078}
}
Kostenlos starten →